|
Volumn 161, Issue 2, 2013, Pages 279-280
|
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy
|
Author keywords
Eculizumab; Haematopoietic stem cell transplantation; Thrombotic microangiopathy
|
Indexed keywords
BORTEZOMIB;
CYCLOSPORIN A;
DEXAMETHASONE;
DOXORUBICIN;
ECULIZUMAB;
FOSCARNET;
MELPHALAN;
MEPREDNISONE;
RITUXIMAB;
THALIDOMIDE;
ADULT;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CASE REPORT;
CYTOMEGALOVIRUS INFECTION;
DISEASE SEVERITY;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
EPSTEIN BARR VIRUS INFECTION;
GRAFT VERSUS HOST REACTION;
HUMAN;
LETTER;
MALE;
MIXED INFECTION;
MULTIPLE MYELOMA;
PRIORITY JOURNAL;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
TRANSPLANTATION ASSOCIATED THROMBOTIC MICROANGIOPATHY;
WHOLE BODY RADIATION;
ANTIBODIES, MONOCLONAL, HUMANIZED;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MALE;
MIDDLE AGED;
MULTIPLE MYELOMA;
THROMBOTIC MICROANGIOPATHIES;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 84875803456
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/bjh.12202 Document Type: Letter |
Times cited : (67)
|
References (4)
|